These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 111372)

  • 1. Serologic analyses of an immunosuppressive cell-free factor from mastocytoma cells and neutralization by antiserum.
    Watanabe M
    Tohoku J Exp Med; 1979 Jun; 128(2):151-9. PubMed ID: 111372
    [No Abstract]   [Full Text] [Related]  

  • 2. Serologic and immunochemical characterization of an immunosuppressive soluble factor from mastocytoma-bearing mice.
    Wantanabe M; Pan SH; Friedman H
    J Natl Cancer Inst; 1978 Jul; 61(1):249-54. PubMed ID: 78985
    [No Abstract]   [Full Text] [Related]  

  • 3. Antibody mediated neutralization of immunosuppression induced by mastocytoma ascites fluids.
    Watanabe M; Pan S; Friedman H
    Proc Soc Exp Biol Med; 1978 Jun; 158(2):238-41. PubMed ID: 79184
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunosuppression induced in vitro by mastocytoma tumor cells and cell-free extracts.
    Kamo I; Patel C; Kateley J; Friedman H
    J Immunol; 1975 Jun; 114(6):1749-56. PubMed ID: 805176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of in vitro immune responsiveness of mastocytoma-suppressed splenocytes by activated T cells.
    Kamo I; Patel C; Patel N; Friedman H
    J Immunol; 1975 Aug; 115(2):382-6. PubMed ID: 807635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential immunosuppressive effects of ascites fluid from mastocytoma-bearing mice on primary vs secondary immunocyte responses.
    Kamo I; Friedman H
    J Immunol; 1978 Feb; 120(2):558-62. PubMed ID: 413868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a dialyzable immunosuppressive fraction from mastocytoma culture supernatants (39901).
    Kamo I; Friedman H
    Proc Soc Exp Biol Med; 1977 Oct; 156(1):177-80. PubMed ID: 410034
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of humoral factors of the mastocytoma P815 cells on the formation of allospecific killers in mixed culture of lymphocytes and their cytotoxic activity].
    Medvedev AE; Dostman U; Flegel' A
    Biull Eksp Biol Med; 1989 Aug; 108(8):224-6. PubMed ID: 2529921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].
    Medvedev AE; Fuks BB
    Biull Eksp Biol Med; 1989 Aug; 108(8):194-6. PubMed ID: 2508789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive factors from mastocytoma cells cultured in serum-free medium.
    Nakamura M; Ishida N; Kamo I
    J Natl Cancer Inst; 1980 Oct; 65(4):759-68. PubMed ID: 6775120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor cell threshold required for suppression of macrophage inflammation.
    Normann SJ
    J Natl Cancer Inst; 1978 May; 60(5):1091-6. PubMed ID: 417187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential depression of IgM producing immunocytes during mastocytoma-induced immunosuppression.
    Friedman H; Kamo I
    Proc Soc Exp Biol Med; 1978 Mar; 157(3):381-5. PubMed ID: 416442
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumour-associated antigens of the mouse P-815 mastocytoma cell: evidence for an antigen with H-2-like characteristics.
    Clemetson KJ; Bertschmann M; Lüscher EF
    Mol Immunol; 1981 Feb; 18(2):135-41. PubMed ID: 6167852
    [No Abstract]   [Full Text] [Related]  

  • 14. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the immune response in vitro and in vivo by splenocytes from tumor-bearing mice.
    Specter SC; Kamo I; Friedman H
    Adv Exp Med Biol; 1976; 66():457-63. PubMed ID: 817575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific cytolytic activity of lymphocytes: effect of antibodies against complement components C2, C3, and C5.
    Henney CS; Mayer MM
    Cell Immunol; 1971 Dec; 2(6):702-5. PubMed ID: 5005914
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of concanavalin A treatment on the allogeneic response of mice to challenge with P 815 mastocytoma: interleukin 2 treatment reverses concanavalin A suppression in vivo.
    Ekstedt RD; Merdian DJ
    Cell Immunol; 1984 May; 85(2):447-58. PubMed ID: 6424952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of the cell-mediated immune response. I. The number of cytolytically active mouse lymphoid cells induced by immunization with allogeneic mastocytoma cells.
    Henney CS
    J Immunol; 1971 Dec; 107(6):1558-66. PubMed ID: 5000987
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumor-induced immunosuppression.
    Friedman H; Specter S; Watanabe M; Pan SH
    Am J Pathol; 1978 Nov; 93(2):499-514. PubMed ID: 102206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.